ALF Celebrates Five Decades of Impact at 50th Anniversary National Legacy Gala
Article excerpt
Highlighted: the sentence this signal was extracted from
Honoring the Achievements of UPMC, AstraZeneca, Dr. Arun Sanyal and NOVO for transformative contributions to the liver community FAIRFIELD, N.J., Oct. 14, 2026 /PRNewswire/ -- American Liver Foundation (ALF) will commemorate five decades of service to patients and families as well as medical professionals and leading organizations at its 50th Anniversary National Legacy Gala on Wednesday, Oct. 28, at Gotham Hall in New York City. ALF will celebrate its legacy through tributes to multiple awardees – UPMC (Transplant Legacy Award), AstraZeneca (Patient Impact Award), Arun Sanyal, MD , of Virginia Commonwealth University (Leadership Award), and NOVO (Leadership Innovation Award). In addition, ALF will present its Leadership Award for Public Service to Frank A. Anania, MD, of the Food and Drug Administration (FDA) and Jay H. Hoofnagle, MD, of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Finally, ALF will award its Distinguished Scientific Achievement Award (DSAA) to Director and Professor Michael Karin, PhD, of the Center for Metabolic and Liver Diseases at Sanford Burnham Prebys Medical Discovery Institute. Each recipient represents a shared commitment to better the lives of liver patients and highlights ALF's past, present and future accomplishments on behalf of the 100 million Americans living with some form of liver disease. "As American...
Keep reading with a free account
The rest of this article, and every signal for UPMC, is in your free account.
